Live
- Taluk Guarantee panel
- Uber Launches Uber Moto Women for Safer and Flexible Rides in Bengaluru
- ‘Fear’ pre-release event creates waves
- Champions Trophy 2025 Host Change? Indian Broadcaster's Promo Sparks Controversy
- Nabha Natesh introduced as Sundara Valli from ‘Swayambhu’
- Aamir Khan praises Upendra's ‘UI: The Movie’ ahead of its release
- Celebrations: Keerthy Suresh ties the knot with Antony Thattil
- Indian scientists develop flexible near-infrared devices for wearable sensors
- Wordle Answer and Hints for Today (December 12, 2024) – Solve Wordle #1272
- Kiara blazing through fashion and film
First nasal spray for Covid launched in India
First nasal spray for Covid launched in India
Highlights
For the treatment of adult patients suffering from Covid-19, pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India. The nasal spray was launched by the company in partnership with SaNOtize.
New Delhi: For the treatment of adult patients suffering from Covid-19, pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India. The nasal spray was launched by the company in partnership with SaNOtize. "Phase 3 trials in India met the key endpoints and demonstrated reduction of viral load of 94 per cent in 24 hours and 99 per cent in 48 hours. Nitric Oxide Nasal Spray (NONS) was safe and well-tolerated in Covid patients. Glenmark to market NONS under the brand name FabiSpray," the company said in a statement.
Next Story
ADVERTISEMENT
